Valuation dashboard for Tivic Health Systems, Inc. (TIVC) with P/E N/A, P/B 0.07, EV/EBITDA -0.50 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services.
Analysis Summary
Tivic Health Systems, Inc. reported revenue of $382000 in the most recent fiscal year, growing at a 5-year CAGR of -15.0%.
Trailing-twelve-month margins: gross margin 5.2%, operating margin 105.9%, net margin 120.2%.
At the current price of $0.26, TIVC has negative trailing earnings (P/E not meaningful) and an ROE of -165.44%. Market capitalisation stands at $0M.
Balance sheet quality for TIVC: current ratio of 20.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.07 |
| EV / EBITDA | -0.50 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-3.45 |
| vs Current Price | -1440.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| TIVC | Tivic Health Systems, Inc. | 0.07 | -165.4% | ||
| ALC | Alcon Inc. | $32.2B | 51.85 | 1.52 | |
| 0A0D.L | Alcon Inc. | $27.1B | |||
| STE | STERIS plc | $20.5B | |||
| 0JZ2.L | Masimo Corporation | $9.5B | 9.69 | -21.0% | |
| 0QLQ.L | Ypsomed Holding AG | $4.8B | |||
| 0A05.L | Medacta Group S.A. | $2.3B |
Price
| Price | $0.26 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -165.44% |
| Return on Invested Capital | -55.13% |
| Return on Assets | -57.74% |
| Gross Margin | 516.03% |
| Operating Margin | 10587.18% |
| Net Margin | 12019.23% |
Related companies: BBLG · BJDX · CNTX · HSCS · MRAI · NUWE · PETV
Explore sector: Healthcare · Medical - Specialties
More sections of TIVC: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks